Libra Infusions Limited announcements
229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2009 (10).
- Normal trading of the shares of the company will resume on 17.11.09 following the starting date of Book-Closure.
Normal trading of the shares of the company will resume on 17.11.09 following the starting date of Book-Closure.
- Trading of the shares of the company will remain suspended on 16.11.09, as Book Closure will start from 17.11.09.
Trading of the shares of the company will remain suspended on 16.11.09, as Book Closure will start from 17.11.09.
- As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2009 (July - September 2009), the Compa
As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2009 (July - September 2009), the Company has reported net profit after tax of Tk. 1.52 million with EPS of Tk. 12.11, Net Asset Value (NAV) of Tk. 87.77 million and Net Operating Cash Flow per share of Tk. 23.05 for the 1st quarter ended on 30th September 2009.
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 12.11.09 to 15.11.09. Trading of the shares of the company will remain suspended on 16.11.09 as Book Closure will start from 17.11.09.
- The company has further informed that due to unavoidable circumstances the Book Closure date of the company will be from
The company has further informed that due to unavoidable circumstances the Book Closure date of the company will be from 17.11.09 to 25.11.09 instead of earlier declared 02.11.09 to 16.11.09. Other information of the AGM as announced earlier. The company has also reported Net profit after tax of Tk. 4.37 m., Net Asset Value (NAV) of Tk. 86.25 m., Earning Per share of Tk. 34.93 and Net Operating Cash Flow per share of Tk. (186.41) for the year ended on 30th June, 2009.
- There will be no price limit on the trading of the shares of the company on 28.10.09 following its corporate declaration
There will be no price limit on the trading of the shares of the company on 28.10.09 following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 15% for the year 2008-2009. Date of AGM: 17.12.09, Time: 11.00 AM
The Board of Directors has recommended cash dividend @ 15% for the year 2008-2009. Date of AGM: 17.12.09, Time: 11.00 AM, Venue: Auditorium of IDB Bhaban (3rd floor), Sher-e-Bangla Nagar, Agargaon, Dhaka-1207. Book Closure: 02.11.09 to 16.11.09.
- In response to a DSE query dated 30.09.09, the company has informed that there is no undisclosed price sensitive informa
In response to a DSE query dated 30.09.09, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- The company has informed that ICB has sanctioned an amount of Tk. 15.00 crore to the company as Debenture Scheme for exp
The company has informed that ICB has sanctioned an amount of Tk. 15.00 crore to the company as Debenture Scheme for expansion of the project of Libra Infusions Limited subject to the approval of Regulatory Authorities.
- As per un-audited half yearly accounts as on 31.12.08, the Company has reported profit after tax of Tk. 2.91 m. with EPS
As per un-audited half yearly accounts as on 31.12.08, the Company has reported profit after tax of Tk. 2.91 m. with EPS of Tk. 23.22 as against last year's half yearly of Tk. 3.43 m. and Tk. 27.39 respectively.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.